The major cause of mortality in diabetes remains cardiovascular disease (CVD). Thus, any risk factors associated with CVD must be aggressively treated in patients with diabetes. Hypertension is one of these risk factors and should be appropriately managed in such individuals. The advent of new glucose lowering drugs such as sodium-glucose cotransporter
2 inhibitors may provide clinicians with additional opportunity to reduce BP.
Modern Medicine – Issue 6 2019